ARTICLE | Financial News
Amicus planning follow-on
March 2, 2012 1:54 AM UTC
Amicus Therapeutics Inc. (NASDAQ:FOLD) said late Thursday it is planning a follow-on underwritten by Leerink and Cowen. Amicus' Amigal migalastat, a small molecule that enhances alpha galactosidase A ...